FFMMX
Price
$64.81
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
SLVIX
Price
$47.84
Change
+$0.24 (+0.50%)
Updated
Jul 31 closing price
Net Assets
3.15B
Interact to see
Advertisement

FFMMX vs SLVIX

FFMMX vs SLVIX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFMMX has more cash in the bank: 118B vs. SLVIX (3.15B). FFMMX pays higher dividends than SLVIX: FFMMX (1.65) vs SLVIX (1.36). FFMMX was incepted earlier than SLVIX: FFMMX (6 years) vs SLVIX (25 years). SLVIX (0.73) is less costly to investors than FFMMX (0.36). FFMMX is a more actively managed with annual turnover of: 30.00 vs. SLVIX (28.00). SLVIX has a lower initial minimum investment than FFMMX: SLVIX (0) vs FFMMX (250). SLVIX annual gain was more profitable for investors over the last year : 28.63 vs. FFMMX (9.76). SLVIX return over 5 years is better than : 63.73 vs. FFMMX (41.13).
FFMMXSLVIXFFMMX / SLVIX
Total Expense Ratio0.360.5368%
Annual Report Gross Expense Ratio0.360.7349%
Fund Existence6 years25 years-
Gain YTD9.85816.79759%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets118B3.15B3,750%
Annual Yield % from dividends1.651.36122%
Returns for 1 year9.7628.6334%
Returns for 3 years35.5354.9065%
Returns for 5 years41.1363.7365%
Returns for 10 yearsN/A134.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLPC368.46N/A
N/A
Preformed Line Products Company
DYORU10.15N/A
N/A
Insight Digital Partners II
CAE25.83N/A
N/A
CAE Inc
RCKT3.11-0.10
-3.12%
Rocket Pharmaceuticals
KPTI1.92-5.09
-72.61%
Karyopharm Therapeutics Inc.